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E2F and Cell Proliferation: Minireview
A World Turned Upside Down
Robert A. Weinberg quiescence by serum starvation can be driven all the
way through G1 into S by ectopic expression of an E2F,Whitehead Institute for Biomedical Research
Department of Biology, M.I.T. specifically E2F-1 (Johnson et al., 1993; Qin et al., 1994).
This unusual trait - the ability of a single transcriptionCambridge, Massachusetts 02142
factor to drive progression all the way through G1 - is
shared, to this writer's knowledge, with only a singleThe cottage industry of inactivating genes in the mouse
germline is growing by leaps and bounds. However, the other transcription factor, the MYC oncoprotein. Hence,
the E2Fs and MYC would appear to sit high in the hierar-making of such mice hardly offers a guaranteed route
to interesting results. Often, the phenotypes of the ge- chy that orchestrates the complex succession of events
that represents the G1 phase.netically altered mice reinforce already established con-
cepts or are uninformative because of early embryonic Topsy-Turvy Mice
The two groups that undertook to inactivate the E2F-1lethality. On occasion, though, knockout mice do indeed
tell us something novel and fully unexpected. Two re- gene in the mouse germline had every right to expect
some interesting phenotypes. The fact that there areports in this issue describe mutant mice with pheno-
types that are precisely opposite to those predicted by five E2Fs suggests a measure of functional redundancy,
reducing the specter of uninformative, early embryonicconventional wisdom (Field et al., 1996; Yamasaki et al.,
1996). lethality. Perhaps, they thought, that the various E2Fs
(or at least the three closely allied E2Fs-1,-2 and 23)Powerful Transcription Factors
The E2F transcription factors - the objects of study in would be used in different tissues to differing extents,
yielding tissue-specific developmental effects when onethese knockout mice - play an especially influential role
in advancing mammalian cells through their growth cy- or another E2F gene was inactivated in the germline.
The expected outcomes were clear: since E2Fs drivecles. The term ªE2Fº actually subsumes a group of five
closely related proteins (E2F-1 through 25) and a set cell cycle advance, their absence should yield underde-
veloped or even absent tissues. In fact, few if any ofof partner proteins, members of the DP family of tran-
scription factors. Heterodimers of E2F and DP proteins these outcomeswere observed. The testes in the E2F2/2
mice were initially normal but then atrophied with ad-assemble in various combinations to form functionally
active DNA-binding complexes. These are important for vancing age (Yamasaki et al., 1996; Field et al., 1996).
This atrophy would seem to be due to still uncharacter-regulating gene expression in the G1 phase of the cell
cycle and perhaps in later phases as well. ized defects in the elaboration of or response to specific
hormones such as testosterone. Such aberrations mayThe E2F factors operate under the direct control of
the cell-cycle clock machinery. In mid/late G1, D-type or may not be connected with the ability of certain cell
types to proliferate properly.cyclins and cyclin E, acting together with cyclin-depen-
dent kinases, phosphorylate the retinoblastoma protein Certain exocrine glands were dysplastic, in that cells
of these tissues seem to have passed through aberrant(pRB) and its two cousins, p107 and p130. These three
proteins, which have affinity for binding various E2Fs, cell cycles, as evidenced by their large size and occa-
sional binucleate appearance (Yamasaki et al., 1996)respond to the phosphorylation by releasing the bound
transcription factors; the liberated E2Fs then proceed This too is hardly indicative of a hypoproliferative state.
So, clear signs of the expected proliferative failure wereto trigger expression of genes that enable the cell's
advance into late G1 and S phases (Sherr, 1994; Wein- not seen.
Instead, a fully unanticipated outcome was observedberg, 1995). Viewed in this way, pRB and its cousins
represent an interface between the core cell cycle clock as these mice aged: some of their tissues began to
exhibit hyperplasia and even neoplasia. One researchmachinery and the cell's transcriptional apparatus.
While the above description is correct in outline, it group reports the thymuses of 4-6 week old E2F-12/2
mice are enlarged due to an excess of immature T cellsglosses over important details. E2Fs-1 through 23 pre-
fer to associate with pRB, while the last two (E2F-4 (Field et al., 1996); the other describes a more systemic
lymphoproliferative disorder (Yamasaki et al., 1996). Inand 25) prefer liaisons with p107 and p130. Also, the
association of pRB and its cousins with the E2Fs can older mice, a substantial increase in the mitotic rate of
cells in their thymic cortex becomes apparent. Yamasakioccur while the latter are bound to DNA sites found in
a variety of promoters. The resulting complexes often and collaborators describe an equally unexpected and
dramatic finding in aging mutant mice: many exhibit aactively repress utilization of these promoters rather
than simply occluding the transcription-inducing do- range of tumors, including notably unusual sarcomas of
the reproductive tract, lung tumors, and lymphomas.mains of the E2Fs. As a consequence, the influence of
an E2F site on the expression of a gene may actually Hence, most of the observed consequences of E2F-1
loss are directly opposite to those that were expected.be a repressive one (Weintraub et al., 1992; LaThangue,
1994). Counter-intuitive results like these are the stuff of
great science, because they force us to re-examine andAccumulating evidence suggests that pRB and possi-
bly its cousins reversibly associate with a number of revise our paradigms. Unfortunately, mice do not always
give us clear guidance into how we should rethink ourother proteins besides the E2Fs. But the E2Fs seem to
be especially important. Their preeminent role is indi- mechanistic models. The powers of the mouse genetics
used here are counter-balanced by its pitfalls. Alteringcated by a simple experiment: cells that are held in
Cell
458
the genes of a mouse allows one to rise above the actively repress transcription. At the same time, they
note the two countervailing effects on cell proliferation:narrow arena of gene-cell interaction to view the larger
and more interesting interplay between genes and tis- ectopically expressed E2F-1 can drive cells through G1
and, once they have moved into S phase, cause cellssues. At the same time, the complexity of tissue physiol-
ogy often deprives one of clear insight, if only because to become apoptotic (Johnson et al., 1993; Qin et al.,
1994). Hence, E2F can provoke cell proliferation anda number of alternative mechanistic models become
plausible. can also cause the demise of a cell, thereby neutralizing
any mitogenic effects that it or other signals have ex-Two Rationales
The unexpectedly high proliferation of several cell types erted.
Given these opposing effects, a variety of specula-in these knockout mice can be rationalized by two
classes of conceptual models. The first class proposes tions become possible, but they remain nothing more
than that. For example, the observation that E2F-1, whenthat the observed effects are cell-autonomous. Thus, the
cells that have become hyperplastic and then cancerous ectopically expressed, causes cultured cells to undergo
apoptosis, may or may not mean that cells normallyhave done so because a critical component (E2F-1) of
their growth-regulating circuitry has been deleted, re- modulate their own endogenous E2F-1 expression as a
means of inducing their own apoptosis. Such a mecha-sulting in their inability to make appropriate decisions
about their own growth, apoptosis, or post-mitotic dif- nism could be invoked to explain the reduced tendency
to apoptose seen in the E2F-12/2 lymphocytes reportedferentiation.
The other, non-cell-autonomous model, equally plau- in one of these two papers (Field et al., 1996).
The fact that E2F can serve to repress transcriptionsible a priori, states that the cell populations in these
mice that were hyperplastic (and later neoplastic) began by attracting pRB might imply that a prime effect of such
repression is to shut down cellular growth-promotingto grow abnormally because of defects in their environ-
ment. For example, the heterotypic interactions be- genes. This in turn could explain why the deletion of
E2F-1 leads to hyperplasia. But this mechanistic modeltween dissimilar cell types in a tissue often include the
exchange of growth-inhibitory signals. If one cell type seems a bit too glib. After all, it is just as plausible that
E2F-1 plays an even more important role in repressingis responsible for suppressing the proliferation of a
neighboring cell layer, then the absence of the first may growth-inhibitory genes, leading to precisely opposite
effects when deleted from the cell's repertoire of tran-permit the second to initiate uncontrolled growth.
Hence, the observed runaway proliferation in certain scriptional regulators.
Name Callingtissues of the E2F-12/2 mice may be due to the underde-
velopment of tissues normally responsible for releasing Finally, there is the issue of nomenclature. E2F-1 is
clearly an oncogene; when co-expressed with othergrowth-inhibitory signals. This line of thinking clings,
perhaps unrealistically, to the notion that many of the known oncogenes, it leads to cellular transformation,
thereby conforming to a widely accepted operationaleffects of E2F-1 deletion will ultimately be explainable
in terms of the inability of certain cell types to proliferate. definition of an oncogene (Johnson et al., 1994; Singh
et al., 1994, Xu et al., 1995). But the papers in this issueThe authors of both reports limit their mechanistic
speculations to the first class of models involving cell- of Cell show that E2F-1 gene deletion also leads to
cancer. In this sense, E2F-1 is also a tumor suppressorautonomous effects. The available evidence supporting
one or the other side of this argument comes from the gene, indeed the first gene to claim membership in the
twogene classes. Is thisa nomenclatural sleightof hand,single observation that the cultured cortical thymocytes
from the E2F-12/2 mice are less susceptible to apoptosis or does E2F-1 (and perhaps its sibs in the E2F family)
really have a foot in both warring camps?in vitro than are their wild-type counterparts. This favors
cell-autonomous thinking but still does not prove it. The term ªtumor suppressor geneº is often abused.
The literature contains a number of reports in which theGenes and Tissues
Like many who are altering the mouse germline, the growth-inhibitory effects of certain genes are described
following the ectopic expression of these genes in oneauthors of these two reports find themselves gazing
across a wide and deep chasm. Standing on one side, or another type of cancer cell. A frequent conclusion is
that the genes under study are functioning as tumorthey have relatively secure footing in the molecular biol-
ogy and biochemistry of their genes and proteins and suppressors. In truth, an observation of a gene's growth-
inhibitory powers says rather little about its normalphys-the effects that their genes exert on cell physiology. At
great distance on the other side are the complex effects iologic role. After all, almost any gene will create some
functional imbalance in a cell and slow down growthon tissue and organismic phenotype created by their
gene alterations. Building a bridge across this chasm when it is ectopically expressed at high enough levels.
Some oncogenes will even shut down cell growth.will be very challenging. It will likely be a number of years
before we understand with any precision why E2F-1 The present papers embrace a more useful and credi-
ble operational definition of a tumor suppressor gene:inactivation leads to many of the phenotypes described
here. a gene which, when deleted from the genome of a cell
or organism, encourages the appearance of a tumor.The authors note an interesting symmetry. The E2F
transcription factors can participate in two diametrically The two papers in this issue of Cell would seem to
have satisfied these criteria by studying the effects ofopposite effects on transcription. As described above,
when complexed directly to DNA in the absence of pRB, germline E2F-1 gene alteration on tumor susceptibility
and by analyzing the growth properties of E2F2/2 thymo-the E2Fs can act as strong inducers of transcription;
when pRB associates with a DNA-bound E2F, it can cytes in culture.
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Many of the tumor suppressor genes studied to date
can cause cancer predisposition when present in the
germline as mutant alleles in a heterozygous configura-
tion. To be sure, the great bulk of the hyperplastic and
neoplastic outcomes reported in these papers are asso-
ciated with germline homozygosity of null alleles at the
E2F-1 locus. But significantly, several of the mice that
were heterozygous for an inactive allele of E2F-1 devel-
oped tumors similar to those seen in the homozygotes.
By this criterion, germline null alleles of E2F-1 parallel
the behavior of other known tumor suppressor genes.
The slightly reduced ability of E2F-12/2 thymocytes
to enter apoptosis in vitro would also seem to support
the candidacy of E2F-1 as a tumor suppressor that oper-
ates on a cell autonomous basis. Here, however, there
are alternative explanations: perhaps these E2F2/2 thy-
mocytes have not been allowed by their in vivo environ-
ment to differentiate in precisely the same way as their
normal counterparts and therefore may not have devel-
oped to a state where they have acquired equal suscep-
tibility to apoptosis. Still, these papers direct our minds
to a new way of conceptualizing cellular growth control.
Controllers may not be simply promoters or inhibitors
of proliferation. Instead, as the authors of these reports
would suggest, a single protein may act as either de-
pending on its concentration in the cell.
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